Sale!

GCNT2 Gene Cataract Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GCNT2 gene cataract autosomal dominant genetic test is a specialized diagnostic tool designed to identify mutations in the GCNT2 gene, which are associated with a form of cataract inherited in an autosomal dominant manner. Cataracts, characterized by the clouding of the eye’s lens, can lead to diminished vision and, if untreated, blindness. The specific mutations in the GCNT2 gene linked to this condition can result in an early onset of cataract development, distinguishing it from age-related cataracts.

This genetic test is crucial for families with a history of early cataract development, as it helps in the early detection and management of the condition. Early diagnosis can lead to timely interventions, potentially preserving vision and improving the quality of life for affected individuals. Moreover, understanding the genetic basis of the condition can provide valuable information for family planning and genetic counseling.

The test is available at DNA Labs UAE, a leading facility in genetic diagnostics, offering a comprehensive range of genetic testing services. The cost of the GCNT2 gene cataract autosomal dominant genetic test is 4400 AED. This price reflects the intricate processes involved in genetic analysis, including DNA extraction, amplification, and sequencing, which are necessary to accurately identify mutations in the GCNT2 gene.

By opting for this test at DNA Labs UAE, individuals and families gain access to state-of-the-art genetic testing technologies, expert interpretation of results, and personalized advice on managing and mitigating the risks associated with hereditary cataracts.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GCNT2 Gene Cataract Autosomal Dominant Genetic Test

At DNA Labs UAE, we offer the GCNT2 Gene Cataract Autosomal Dominant Genetic Test for individuals who suspect they may be at risk for this condition. Our comprehensive test provides valuable insights into the genetic factors that contribute to autosomal dominant cataracts.

Test Details

The GCNT2 gene is associated with autosomal dominant cataracts, a type of cataract inherited from one parent who carries the mutated gene. The GCNT2 gene plays a crucial role in the production of glycoproteins, which are proteins with sugar molecules attached to them. These glycoproteins are essential for cell signaling, adhesion, and immune system function.

Changes or mutations in the GCNT2 gene can affect the structure and function of the beta-1,3-N-acetylglucosaminyltransferase enzyme, leading to disruptions in the production of glycoproteins. This disruption can interfere with the normal development and maintenance of the lens in the eye, resulting in the formation of cataracts.

Method

We utilize NGS (next-generation sequencing) technology for our GCNT2 Gene Cataract Autosomal Dominant Genetic Test. This advanced genetic testing method involves analyzing the DNA sequence of the GCNT2 gene to identify any mutations or changes that may be present.

Components and Price

  • Test Name: GCNT2 Gene Cataract Autosomal Dominant Genetic Test
  • Components: Blood or Extracted DNA or One drop Blood on FTA Card
  • Price: 4400.0 AED

Sample Condition and Report Delivery

We accept blood samples or extracted DNA for this test. Additionally, we also accept one drop of blood on an FTA card. The report delivery time is approximately 3 to 4 weeks.

Test Type and Doctor

The GCNT2 Gene Cataract Autosomal Dominant Genetic Test falls under the category of Ophthalmology Disorders. Our highly qualified Ophthalmologists oversee this test to ensure accurate results.

Test Department and Pre Test Information

This test is conducted in our Genetics department. Prior to the test, it is essential to provide the clinical history of the patient who is undergoing the GCNT2 Gene Cataract Autosomal Dominant NGS Genetic DNA Test. Additionally, a Genetic Counselling session is recommended to draw a pedigree chart of family members affected by GCNT2 Gene Cataract Autosomal Dominant NGS Genetic DNA Test gene GCNT2.

Benefits of GCNT2 Gene Cataract Autosomal Dominant Genetic Test

  • Diagnosis of autosomal dominant cataracts
  • Prediction of the risk of developing cataracts in family members
  • Genetic counseling and guidance for affected individuals and their families

By undergoing the GCNT2 Gene Cataract Autosomal Dominant Genetic Test, individuals can gain valuable insights into their genetic predisposition for this condition. This knowledge allows for early detection, proactive management, and informed decision-making.

Don’t wait until it’s too late. Take control of your eye health today with DNA Labs UAE’s GCNT2 Gene Cataract Autosomal Dominant Genetic Test.

Test Name GCNT2 Gene Cataract autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ophthalmology Disorders
Doctor Ophthalmologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GCNT2 Gene Cataract, autosomal dominant NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GCNT2 Gene Cataract, autosomal dominant NGS Genetic DNA Test gene GCNT2
Test Details

The GCNT2 gene is associated with autosomal dominant cataracts, which is a type of cataract that is inherited from one parent who carries the mutated gene. The GCNT2 gene provides instructions for making an enzyme called beta-1,3-N-acetylglucosaminyltransferase, which is involved in the production of glycoproteins. Glycoproteins are proteins that have sugar molecules attached to them, and they play important roles in cell signaling, cell adhesion, and immune system function.

Mutations in the GCNT2 gene can lead to changes in the structure or function of the beta-1,3-N-acetylglucosaminyltransferase enzyme, which can affect the production of glycoproteins. This can disrupt the normal development and maintenance of the lens in the eye, leading to the formation of cataracts.

NGS (next-generation sequencing) genetic testing can be used to identify mutations in the GCNT2 gene that are associated with autosomal dominant cataracts. This type of genetic testing involves analyzing the DNA sequence of the gene to identify any changes or mutations that may be present. This information can be used to diagnose the condition, predict the risk of developing cataracts in family members, and provide genetic counseling and guidance for affected individuals and their families.